Seung-Ah Lee

Seung-Ah Lee

Auto-generated profile, based on publicly available information

Seung-Ah Lee

Division of Cardiology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2022 in Circulation
Verified
Journal Article
Closed access
PDF file
DPDuk-Woo Park
Duk-Woo Park
JAJung-Min Ahn
Jung-Min Ahn
DKDo-Yoon Kang
Do-Yoon Kang
KKKyung Won Kim
Kyung Won Kim
HKHyun Jung Koo
Hyun Jung Koo
FIfor the ADAPT-TAVR Investigators
for the ADAPT-TAVR Investigators
Background: It is unknown whether the direct oral anticoagulant edoxaban can reduce leaflet thrombosis and the accompanying cerebral thromboembolic risk after transcatheter aortic valve replacement. In addition, the causal relationship of subclinical leaflet thrombosis with cerebral thromboembolism and neurological or neurocognitive dysfunction remains unclear. Methods: We conducted a multicenter, open-label randomized trial comparing edoxaban with dual antiplatelet therapy (aspirin plus clopidogrel) in patients who had undergone successful transcatheter aortic valve replacement and did not have an indication for anticoagulation. The primary end point was an incidence of leaflet thrombosis on 4-dimensional computed tomography at 6 months. Key secondary end points were the number and volume of new cerebral lesions on brain magnetic resonance imaging and the serial changes of neurological and neurocognitive function between 6 months and immediately after transcatheter aortic valve replacement. Results: A total of 229 patients were included in the final intention-to-treat population. There was a trend toward a lower incidence of leaflet thrombosis in the edoxaban group compared with the dual antiplatelet therapy group (9.8% versus 18.4%; absolute difference, −8.5% [95% CI, −17.8% to 0.8%]; P =0.076). The percentage of patients with new cerebral lesions on brain magnetic resonance imaging (edoxaban versus dual antiplatelet therapy, 25.0% versus 20.2%; difference, 4.8%; 95% CI, −6.4% to 16.0%) and median total new lesion number and volume were not different between the 2 groups. In addition, the percentages of patients with worsening of neurological and neurocognitive function were not different between the groups. The incidence of any or major bleeding events was not different between the 2 groups. We found no significant association between the presence or extent of leaflet thrombosis with new cerebral lesions and a change of neurological or neurocognitive function. Conclusions: In patients without an indication for long-term anticoagulation after successful transcatheter aortic valve replacement, the incidence of leaflet thrombosis was numerically lower with edoxaban than with dual antiplatelet therapy, but this was not statistically significant. The effects on new cerebral thromboembolism and neurological or neurocognitive function were also not different between the 2 groups. Because the study was underpowered, the results should be considered hypothesis generating, highlighting the need for further research. Registration: URL: https://www.clinicaltrials.gov . Unique identifier: NCT03284827.

1 April 2019 in The American Journal of Cardiology
Verified
Journal Article
Closed access
HKHo Jin Kim
Ho Jin Kim
JKJoon-bum Kim
Joon-bum Kim
HKHong Rae Kim
Hong Rae Kim
MJMin Ho Ju
Min Ho Ju
DKDo-Yoon Kang
Do-Yoon Kang
SPSeung-Jung Park
Seung-Jung Park

1 January 2024 in Korean Circulation Journal
Verified
Journal Article
Open access
PDF file
YJYeonggul Jang
Yeonggul Jang
HCHyejung Choi
Hyejung Choi
YYYeonyee E. Yoon
Yeonyee E. Yoon
JJJaeik Jeon
Jaeik Jeon
HKHyejin Kim
Hyejin Kim
HCHyuk-Jae Chang
Hyuk-Jae Chang
Jang Y, et al. Korean Circ J. 2024 Aug;54:e103. https://doi.org/10.4070/kcj.2024.0060

15 July 2022 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
SJSuk-Chan Jang
Suk-Chan Jang
JNJin Hyun Nam
Jin Hyun Nam
SLSeung-Ah Lee
Seung-Ah Lee
DADasom An
Dasom An
HKHye-Lin Kim
Hye-Lin Kim
Eui-Kyung LeeEui-Kyung Lee
Eui-Kyung Lee
Background: Transthyretin cardiac amyloidosis, also known as transthyretin cardiomyopathy (ATTR-CM) is a poorly-recognized disease with delayed diagnosis and poor prognosis. This nationwide population-based study aimed to identify disease manifestations, economic burden, and mortality of patients with ATTR-CM. Methods: Data of newly diagnosed patients with ATTR-CM between 2013 and 2018 from the Korean National Health Insurance Service were used, covering the entire population. Patient characteristics included comorbidities, medical procedures, and medication. Healthcare resource utilization and medical costs were observed as measures of the economic burden. The Kaplan–Meier survival curve and years of potential life lost (YPLL) from the general population were estimated for disease burden with ATTR CM. Results: A total of 175 newly diagnosed patients with ATTR-CM were identified. The most common cardiac manifestation was hypertension (51.3%), while the most common non-cardiac manifestation was musculoskeletal disease (68.0%). Mean medical costs at the post-cohort entry date were significantly higher than those at the pre-cohort entry date ($1,864 vs. $400 per patient per month (PPPM), p < 0.001). Of the total medical costs during the study period, the proportion of inpatients cost was 12.9 times higher than the outpatients cost ($1,730 and $134 PPPM, respectively). The median survival time was 3.53 years from the first diagnosis of ATTR-CM, and the mean (SD) YPLL was 13.0 (7.7). Conclusions: Patients with ATTR-CM had short survival and high medical costs. To reduce the clinical and economic burdens, carefully examining manifestations of disease in patients can help with early diagnosis and treatment.

6 June 2024 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YAYura Ahn
Yura Ahn
HKHyun Jung Koo
Hyun Jung Koo
SLSeung Ah Lee
Seung Ah Lee
DJDaSol Jung
DaSol Jung
JKJoon-Won Kang
Joon-Won Kang
DYDong Hyun Yang
Dong Hyun Yang
Research on cardiovascular diseases using CT-derived strain is gaining momentum, yet there is a paucity of information regarding reference standard values beyond echocardiography, particularly in cardiac chambers other than the left ventricle (LV). We aimed to compile CT-derived strain values from the four cardiac chambers in healthy adults and assess the impact of age and sex on myocardial strains. This study included 101 (mean age: 55.2 ± 9.0 years, 55.4% men) consecutive healthy individuals who underwent multiphase cardiac CT. CT-derived cardiac strains, including LV global and segmental longitudinal, circumferential, and transverse strains, left atrial (LA), right atrial (RA), and right ventricle (RV) strains were measured by the commercially available software. Strain values were classified and compared by their age and sex. The normal range of CT-derived LV global longitudinal strain (GLS), global circumferential strain (GCS), and global radial strain (GRS) were −20.2 ± 2.7%, −27.9 ± 4.1%, and 49.4 ± 12.1%, respectively. For LA, reservoir strain, pump strain, and conduit strain were 28.6 ± 8.5%, 13.2 ± 6.4%, and 15.5 ± 8.6%, respectively. The GLS of RA and RV were 27.9 ± 10.9% and −22.0 ± 5.7%, respectively. The absolute values of GLS of RA and RV of women were higher than that in men (32.4 ± 11.4 vs. 24.3 ± 9.1 and −25.2 ± 4.7 vs. −19.4 ± 5.0, respectively; p<0.001, both). Measurement of CT-derived strain in four cardiac chambers is feasible. The reference ranges of CT strains in four cardiac chambers can be used for future studies of various cardiac diseases using the cardiac strains.

1 January 2021 in Journal of Cardiovascular Imaging
Verified
Journal Article
Open access
YYYujin Yang
Yujin Yang
EHEunSoon Hwang
EunSoon Hwang
SLSeung-Ah Lee
Seung-Ah Lee
SLSahmin Lee
Sahmin Lee
DKDae-Hee Kim
Dae-Hee Kim
DKDuk-Hyun Kang
Duk-Hyun Kang
Yang Y, et al. J Cardiovasc Imaging. 2020 Oct;29:e30. https://doi.org/10.4250/jcvi.2020.0244